Advanced search×

A circadian rhythm orchestrated by histone deacetylase 3 controls hepatic lipid metabolism.

Science 331(6022):1315-9 (2011) PMID 21393543 PMCID PMC3389392

Disruption of the circadian clock exacerbates metabolic diseases, including obesity and diabetes. We show that histone deacetylase 3 (HDAC3) recruitment to the genome displays a circadian rhythm in mouse liver. Histone acetylation is inversely related to HDAC3 binding, and this rhythm is lost when HDAC3 is absent. Although amounts of HDAC3 are constant, its genomic recruitment in liver corresponds to the expression pattern of the circadian nuclear receptor Rev-erbα. Rev-erbα colocalizes with HDAC3 near genes regulating lipid metabolism, and deletion of HDAC3 or Rev-erbα in mouse liver causes hepatic steatosis. Thus, genomic recruitment of HDAC3 by Rev-erbα directs a circadian rhythm of histone acetylation and gene expression required for normal hepatic lipid homeostasis.

DOI: 10.1126/science.1198125
Version: za2963e q8za0 q8zb6 q8zc9 q8zd0 q8zea q8zf8 q8zgc

Similar articles you may find interesting…

  1. A circadian rhythm orchestrated by histone deacetylase 3 controls hepatic lipid metabolism.

    Science 331(6022):1315-9 (2011) PMID 21393543 PMCID PMC3389392

    We show that histone deacetylase 3 (HDAC3) recruitment to the genome displays a circadian rhythm in mouse liver. Histone acetylation is inversely related to HDAC3 binding, and this rhythm is lost when HDAC3 is absent. Although amounts of HDAC3 are constant, its genomic recruitment in liver correspon...
  2. PI3K(p110 alpha) protects against myocardial infarction-induced heart failure: identification of PI3K-regulated miRNA and mRNA.

    Arterioscler Thromb Vasc Biol 30(4):724-32 (2010) PMID 20237330

    Activation of PI3K(p110alpha) protects the heart against MI-induced heart failure. Cardiac-selective targets that mediate the protective effects of PI3K(p110alpha) represent new drug targets for heart failure....
  3. Integrated miRNA and mRNA expression profiling of the inflammatory breast cancer subtype.

    Br J Cancer 103(4):532-41 (2010) PMID 20664596 PMCID PMC2939785

    This study represents, to the best of our knowledge, the first integrated analysis of miRNA and mRNA expression in IBC. We identified a set of 13 miRNAs of which expression differed between IBC and non-IBC, making these miRNAs candidate markers for the IBC subtype.British Journal of Cancer advance on...